[MO34] Mini-Oral Session 34　Translational Research / Clinical Pharmacology 5（Basic science, Biomarker）
【E】

[MO34-4] Comparative study on the efficacy and exposure of molecular target agents in NSCLC PDX models with driver mutations

^○Hitomi Jo^1,2, Shigehiro Yagishita², Yoshiharu Hayashi^2,3,4, Shoraku Ryu², Mikiko Suzuki^2,3, Shinji Kohsaka⁵, Toshihide Ueno⁵, Yuji Matsumoto⁵, Hidehito Horinouchi⁷, Yuichiro Ohe⁷, Shun-Ichi Watanabe⁸, Noriko Motoi⁹, Yasushi Yatabe⁹, Hiroyuki Mano⁹, Akinobu Hamada^2,3, Kazuhisa Takahashi¹ (1.Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 2.Division of Molecular Pharmacology, National Cancer Center Research Institute, 3.Department of Medical Oncology and Translational Research, Graduate School of Medical Sciences, Kumamoto University,, 4.Bioanalysis Research Department, CMIC Pharma Science Co., 5.Division of Cellular Signaling, National Cancer Center Research Institute, 6.Department of Endoscopy, Respiratory Endoscopy Division, National Cancer Center Hospital, 7.Department Thoracic Oncology, National Cancer Center Hospital, 8.Department Thoracic Surgery, National Cancer Center Hospital, 9.Department of Diagnostic Pathology, National Cancer Center Hospital)